There are 12 companies in the race to find a vaccine for COVID-19. And global stock markets are already bouncing back hard on the back of news that a solution is close. There’s no doubt it’ll be a great moment for humanity when we get this cure. From an investing point of view, the rewards […]
There are 12 companies in the race to find a vaccine for COVID-19. And global stock markets are already bouncing back hard on the back of news that a solution is close. There’s no doubt it’ll be a great moment for humanity when we get this cure…
When it comes to biotechs, it’s easy to get hung up on drugs. After all, drugs are the centrepiece of healthcare. They are the medicine that cures what ails us. Or at least, that’s the intention. However, as we all know, drugs come in many different shapes and forms. An overlooked but equally important part […]
Governments and central banks around the world are busy forestalling. The question is whether it’s the inevitable. Job losses, bankruptcies, mortgage defaults, corporate bond defaults, austerity or sovereign debt defaults, and plenty more. Does delaying them lead to avoiding them in the end? I’m not so sure, either way. But we’re going to find out […]
When it comes to biotech, it’s easy to get hung up on drugs.Ryan Dinse has spent the last three days covering Synthetic Biology. Or as he likes to call it, ‘synbio’. This is a story that you won’t find anywhere else, and an investment opportunity that can’t be ignored…
Over the past couple of days, I’ve been talking about a paradigm shifting moment in biotech that’s happening right now. And how its implications on the race for a COVID-19 vaccine are just the tip of an exponential iceberg. I recorded a video call with editorial director Greg Canavan earlier this week to explain more […]
Fat Tail Daily is brought to you by the team at Fat Tail Investment Research
Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988
